Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03826771 · ClinicalTrials.gov registry record · Phase 2

Post-Stroke Optimization of Walking Using Explosive Resistance

A Phase 2 study, sponsored by Medical University of South Carolina.

Completed
Registry status
Phase 2
Development phase
48
Enrollment target

NCT03826771 is a Phase 2 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 48 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03826771, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
Phase 2
Development phase
48 participants
Enrollment target

Study Summary

The investigators will study the effects of a 12 week strength training program on individuals who have had a stroke and are depressed to see if this type of exercise training helps treat depression and improves walking function. Our goal is to use the information collected in this study to help design treatments for people who have had a stroke that will help with many of the common consequences of stroke, including depression, muscle weakness and slow walking. Progress toward overcoming some of these issues would be incredibly valuable to any person who has had a stroke and their families.

Interventions

  • BEHAVIORAL Stretching
  • BEHAVIORAL Power training

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2019-02-06
Est. Completion 2024-05-12
Phase Phase 2

What the Registry Record Tells You About NCT03826771

The ClinicalTrials.gov registry entry for NCT03826771 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Stretching is the first listed.

NCT03826771 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03826771 about?

NCT03826771 is a clinical study titled "Post-Stroke Optimization of Walking Using Explosive Resistance". The investigators will study the effects of a 12 week strength training program on individuals who have had a stroke and are depressed to see if this type of exercise training helps treat depression and improves walking function. Our goal is to use the information collected in this study to help des...

What is the current status of trial NCT03826771?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 48 participants. The study started on 2019-02-06. Estimated completion is 2024-05-12.

What interventions are being tested in trial NCT03826771?

The interventions under investigation include: Stretching (BEHAVIORAL), Power training (BEHAVIORAL).

Who is sponsoring clinical trial NCT03826771?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.